ArticleJournal of advanced research2019
Preclinical studies of toxicity and safety of the AS-48 bacteriocin.
Abstract read
In one paragraph
Article in Journal of advanced research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- Pacin, a novel bacteriocin fromMicrobiology spectrum · 2026Article
- Safety Assessment of Enterocin LD3 Purified from a Food-Grade Enterococcus hirae LD3.Probiotics and antimicrobial proteins · 2026Article
- In Vivo Acute Toxicity and Therapeutic Potential of a Synthetic Peptide, DP1 in a Staphylococcus aureus Infected Murine Wound Excision Model.Probiotics and antimicrobial proteins · 2025Article
- Mitigating gut dysbiosis induced by biofilm-forming pathogens: therapeutic potential of LAB-derived bacteriocins.Frontiers in microbiology · 2025Article
- Understanding of probiotic origin antimicrobial peptides: a sustainable approach ensuring food safety.NPJ science of food · 2024Review
- Characterization of a novel circular bacteriocin fromHeliyon · 2024Article
- Bacteriocins: potentials and prospects in health and agrifood systems.Archives of microbiology · 2024Review
- Biosynthesis, classification, properties, and applications ofFrontiers in microbiology · 2024Review
- Synthesis and antimicrobial activity of aminoalkyl resveratrol derivatives inspired by cationic peptides.Journal of enzyme inhibition and medicinal chemistry · 2023Article
- Immunomodulation, Bioavailability and Safety of Bacteriocins.Life (Basel, Switzerland) · 2023Review
- The LiaFSR-LiaX System Mediates Resistance of Enterococcus faecium to Peptide Antibiotics and to Aureocin A53- and Enterocin L50-Like Bacteriocins.Microbiology spectrum · 2023Article
- Resistance to the Bacteriocin Lcn972 Deciphered by Genome Sequencing.Microorganisms · 2023Article
- Identification and Characterization of Three New Antimicrobial Peptides from the Marine MolluskInternational journal of molecular sciences · 2023Article
- Biopreservative efficacy of Enterococcus faecium-immobilised film and its enterocin against Salmonella enterica.AMB Express · 2023Article
- Advances in the preclinical characterization of the antimicrobial peptide AS-48.Frontiers in microbiology · 2023Review
- Embedding Biomimetic Magnetic Nanoparticles Coupled with Peptide AS-48 into PLGA to Treat Intracellular Pathogens.Pharmaceutics · 2022Article
- Use of Bacteriocins and Bacteriocinogenic Beneficial Organisms in Food Products: Benefits, Challenges, Concerns.Foods (Basel, Switzerland) · 2022Review
- In vitro assessment of skin sensitization, irritability and toxicity of bacteriocins and reuterin for possible topical applications.Scientific reports · 2022Article
- Bacteriocin BacSp222 and Its Succinylated Forms Exhibit Proinflammatory Activities Toward Innate Immune Cells .Journal of inflammation research · 2022Article
- Lactococcus lactis Resistance to Aureocin A53- and Enterocin L50-Like Bacteriocins and Membrane-Targeting Peptide Antibiotics Relies on the YsaCB-KinG-LlrG Four-Component System.Antimicrobial agents and chemotherapy · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Rubén CebriánDepartment of Molecular Genetics, Faculty of Science and Engineering, Nijenborgh 7, 9747 AG, University of Groningen, Groningen, the Netherlands.
M Elena Rodríguez-CabezasCIBER-EHD, Department of Pharmacology. Centre for Biomedical Research (CIBM), Avda del Conocimiento s/n, University of Granada, Granada, Spain.
Rubén Martín-EscolanoDepartment of Parasitology, Instituto de Investigación Biosanitaria (ibs.Granada), Hospitales Universitarios de Granada/University of Granada, Severo Ochoa s/n, E-18071 Granada, Spain.
Susana RubiñoDepartment of Microbiology, Faculty of Sciences, Avda Fuentenueva s/n, University of Granada, 18071 Granada, Spain.
María Garrido-BarrosCIBER-EHD, Department of Pharmacology. Centre for Biomedical Research (CIBM), Avda del Conocimiento s/n, University of Granada, Granada, Spain.
Manuel Montalbán-LópezDepartment of Microbiology, Faculty of Sciences, Avda Fuentenueva s/n, University of Granada, 18071 Granada, Spain.
María José RosalesDepartment of Parasitology, Instituto de Investigación Biosanitaria (ibs.Granada), Hospitales Universitarios de Granada/University of Granada, Severo Ochoa s/n, E-18071 Granada, Spain.
Manuel Sánchez-MorenoDepartment of Parasitology, Instituto de Investigación Biosanitaria (ibs.Granada), Hospitales Universitarios de Granada/University of Granada, Severo Ochoa s/n, E-18071 Granada, Spain.
Eva ValdiviaDepartment of Microbiology, Faculty of Sciences, Avda Fuentenueva s/n, University of Granada, 18071 Granada, Spain.
Manuel Martínez-BuenoDepartment of Microbiology, Faculty of Sciences, Avda Fuentenueva s/n, University of Granada, 18071 Granada, Spain.
Clotilde MarínDepartment of Parasitology, Instituto de Investigación Biosanitaria (ibs.Granada), Hospitales Universitarios de Granada/University of Granada, Severo Ochoa s/n, E-18071 Granada, Spain.
Julio GálvezCIBER-EHD, Department of Pharmacology. Centre for Biomedical Research (CIBM), Avda del Conocimiento s/n, University of Granada, Granada, Spain.
Mercedes MaquedaDepartment of Microbiology, Faculty of Sciences, Avda Fuentenueva s/n, University of Granada, 18071 Granada, Spain.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The
Indexed as
Antimicrobial peptidesCytotoxicityHaemolysisMouse modelTopical deliveryZebrafish model
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.